TY - JOUR
T1 - Self-regulating the use of large language models in clinical practice
T2 - a risk-stratified approach
AU - Mohammad, Milan
AU - Jimenez-Solem, Espen
AU - Hejmadi, Michael
AU - Pihl, Andreas
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/.
PY - 2026/5/6
Y1 - 2026/5/6
N2 - The rapid integration of large language models (LLMs) into clinical practice offers promising benefits, including assistance with documentation, decision support and patient communication. However, these advantages are tempered by concerns around model accuracy, data privacy, clinician trust and regulatory responsibility. In this comment, we propose a clinician-led, risk-stratified framework to guide responsible adoption of LLMs in healthcare. The framework categorises applications into four risk tiers: low risk, moderate risk, high risk and critical risk. Each tier demands tailored oversight, validation and governance, with increasing levels of statutory regulatory scrutiny (eg., European Union Artificial Intelligence Act and U.S. Food and Drug Administration) and clinical supervision. We argue that proactive self-regulation combined with ongoing quality management and clinician education is essential to safely integrate LLMs into ongoing care.
AB - The rapid integration of large language models (LLMs) into clinical practice offers promising benefits, including assistance with documentation, decision support and patient communication. However, these advantages are tempered by concerns around model accuracy, data privacy, clinician trust and regulatory responsibility. In this comment, we propose a clinician-led, risk-stratified framework to guide responsible adoption of LLMs in healthcare. The framework categorises applications into four risk tiers: low risk, moderate risk, high risk and critical risk. Each tier demands tailored oversight, validation and governance, with increasing levels of statutory regulatory scrutiny (eg., European Union Artificial Intelligence Act and U.S. Food and Drug Administration) and clinical supervision. We argue that proactive self-regulation combined with ongoing quality management and clinician education is essential to safely integrate LLMs into ongoing care.
KW - Artificial intelligence
KW - Decision Support Systems, Clinical
KW - Health Information Management
KW - Implementation Science
KW - Information Technology
UR - https://www.scopus.com/pages/publications/105038220755
U2 - 10.1136/bmjhci-2025-101921
DO - 10.1136/bmjhci-2025-101921
M3 - Comment/debate
C2 - 42091170
AN - SCOPUS:105038220755
SN - 2632-1009
VL - 33
JO - BMJ Health and Care Informatics
JF - BMJ Health and Care Informatics
IS - 1
M1 - e101921
ER -